Wen S, Zeng J, Zhong L, Ye J, Lai X. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma: Nivolumab and lenvatinib in the treatment of HCC. Cell Mol Biol (Noisy-le-grand) [Internet]. 2022 Nov. 30 [cited 2024 May 17];68(11):53-7. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4593